| 4.11 -0.03 (-0.72%) | 08-27 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.05 | 1-year : | 5.9 |
| Resists | First : | 4.32 | Second : | 5.05 |
| Pivot price | 3.65  |
|||
| Supports | First : | 3.45 |
Second : | 2.92 |
| MAs | MA(5) : | 4.13 |
MA(20) : | 3.51 |
| MA(100) : | 3.31 |
MA(250) : | 3.75 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 88 |
D(3) : | 91.1 |
| RSI | RSI(14): 69.3 |
|||
| 52-week | High : | 5.07 | Low : | 2.77 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SBC ] has closed below upper band by 22.3%. Bollinger Bands are 132.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.14 - 4.16 | 4.16 - 4.18 |
| Low: | 4.02 - 4.05 | 4.05 - 4.08 |
| Close: | 4.07 - 4.11 | 4.11 - 4.15 |
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
Thu, 27 Aug 2026
SBC Medical expects clinic AI efforts to add up to $15M in revenue - Stock Titan
Mon, 24 Aug 2026
SBC Medical expects AI at its clinics to add up to $15 million in annual revenue - Stock Titan
Wed, 19 Aug 2026
SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32% - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Consulting Services
|
|
| Shares Out | 103 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 81.5 (%) |
| Held by Institutions | 4.4 (%) |
| Shares Short | 814 (K) |
| Shares Short P.Month | 549 (K) |
| EPS | 0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.56 |
| Profit Margin | 27.9 % |
| Operating Margin | 38.5 % |
| Return on Assets (ttm) | 11.3 % |
| Return on Equity (ttm) | 18.9 % |
| Qtrly Rev. Growth | 13.3 % |
| Gross Profit (p.s.) | 1.22 |
| Sales Per Share | 1.7 |
| EBITDA (p.s.) | 0.66 |
| Qtrly Earnings Growth | 338.8 % |
| Operating Cash Flow | 63 (M) |
| Levered Free Cash Flow | 63 (M) |
| PE Ratio | 8.56 |
| PEG Ratio | 1.7 |
| Price to Book value | 1.59 |
| Price to Sales | 2.41 |
| Price to Cash Flow | 6.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|